Long‐term humoral immunity decline in hemodialysis patients following severe acute respiratory syndrome coronavirus 2 vaccination: A cohort study

BACKGROUND AND AIMS: Dialysis patients are extremely vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection with high rates of hospitalization and mortality rates. In January 2021, the University of Virginia Dialysis Program initiated a program‐wide vaccination campaign...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggins, Eibhlin, Sharma, Binu, Ma, Jennie Z., Gautam, Jitendra, Bowman, Brendan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528757/
https://www.ncbi.nlm.nih.gov/pubmed/36210878
http://dx.doi.org/10.1002/hsr2.854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528757/
https://www.ncbi.nlm.nih.gov/pubmed/36210878
http://dx.doi.org/10.1002/hsr2.854

Ejemplares similares